secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001213900-24-066130
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics shareholders re-elect board, ratify auditor, approve equity plan increase
--------------------------------------------------------------------------------

- All five incumbent directors re-elected; vote totals ranged from 637,415 to 700,399 for each.
- Ratification of WithumSmith+Brown as auditor passed with 1,763,403 votes for (79.1% of votes cast).
- Amendment to 2022 Omnibus Equity Plan approved to increase reserved shares from 591,317 to 1,091,317.
- Quorum of 2,230,078 shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/0001213900-24-066130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/ea0210818-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-066130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer